Frequently Asked Questions About the CA 15-3 Test

If your doctor has ordered a CA 15-3 test, you may have questions about what it is and what it measures. Here are straightforward answers to some of the most common ones.

What is CA 15-3? 

CA 15-3 is a protein that may be present in the blood. Small amounts of it are present in healthy people, but in some people with breast cancer, especially in advanced stages, the levels can become quite high. There’s a blood test that tells how much is in the body at any one time. 

Is it used to diagnose cancer? 

Not at all. A CA 15-3 result by itself can’t say for sure if someone has cancer or not. Normal levels are seen in some people with breast cancer, and high levels may be seen in people who don’t have cancer. This is why doctors always use it along with X-rays, biopsies, and other lab results to get a fuller picture of a patient’s health.

What is it mainly used for then? 

The main goal is surveillance. After a diagnosis of breast cancer is made and treatment is started, CA 15-3 levels are watched over time to help assess the body’s response. If it is decreasing, it may be an indication that treatment is working well. If levels are rising, it may be a sign that the cancer is advancing or that the current approach needs to be re-evaluated.

Does it connect to any specific treatments? 

Yes, it can. Targeted therapies are sometimes given to people with hormone receptor-positive, HER2-negative advanced breast cancer as part of their treatment plan. One of these drugs is Everolimus, an mTOR inhibitor that is sometimes given to this group of patients along with hormone therapy. 

When Everolimus is part of the treatment, monitoring of CA 15-3 becomes an important tool to understand how well the therapy is working. Monitoring CA 15-3 levels regularly while on Everolimus treatment helps doctors decide whether to continue, modify, or completely change the treatment plan.

Can other conditions raise CA 15-3 levels? 

Yes, and it is good to know this. Elevated CA 15-3 is not specific for breast cancer. Other cancers and non-cancerous conditions, such as liver disease, endometriosis, and benign breast conditions, can also affect the result. This is one of the main reasons that the test is never interpreted in isolation. Context is very important. Context is very important.

How is the test done? 

Just a simple blood draw like any other routine blood test. Usually, no special preparation is necessary beforehand, but your doctor may give you specific instructions if other tests are scheduled at the same visit.

How often will I need it? 

It varies from person to person. CA 15-3 may be checked at regular intervals during the course of treatment in patients who are currently under treatment. People in remission or in a monitoring phase may be tested less frequently. Your oncologist will determine the right schedule for you based on your individual situation and stage of treatment.

Wrapping Up

Doctors can easily measure CA 15-3, and it takes little effort to see how breast cancer responds to treatment over time. Used alone, it is not a diagnostic tool, but as part of an overall monitoring program, especially for patients on targeted therapies such as Everolimus, it provides essential information that can directly impact therapeutic decisions. If you have questions about your results, always ask your healthcare provider for appropriate context and guidance.